KRAS and familial pancreatic carcinoma: In addition, Nox4 levels were increased during pancreatic cancer progression in a KRASG12D-driven mouse model of pancreatic cancer, highlighting a link between high NOX4 expression and advanced stage of a KRAS-driven tumor type24.